Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10612studies shown

Showing 7,129-7,140 of 10,612

Drug study icon

CompletedNCT00338962

Naltrexone & SSRI in Alcoholics With Depression/PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Depression, PTSDDrugFrom 21 Years to 75 Years

Countries: United States
Sponsor: Yale University
Condition: Depression, PTSD

Drug study icon

CompletedNCT00502216

Naltrexone and Varenicline: Weight Gain and Tolerability in Cigarette Smokers

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 75 Years

Countries: United States
Sponsor: Yale University
Condition: Addiction

Drug study icon

CompletedNCT00218153

Naltrexone Augmentation of Nicotine Patch Therapy - 1

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 99 Years

Countries: United States
Sponsor: National Institute on Drug Abuse (NIDA)
Condition: Addiction

Drug study icon

CompletedNCT01866098

Naltrexone for Antipsychotic-Induced Weight Gain

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Schizophrenia, Bipolarity, ...DrugFrom 18 Years to 75 Years

Countries: United States
Sponsor: Yale University
Condition: Schizophrenia, Bipolarity, ...

Drug study icon

CompletedNCT00223275

Naltrexone for Bipolarity and Alcohol Dependence

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDrugFrom 18 Years to 70 Years

Countries: United States
Sponsor: University of Texas Southwestern Medical Center
Condition: Bipolarity

Drug study icon

CompletedNCT02026011

Naltrexone for Individuals of East Asian Descent

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 21 Years to 65 Years

Countries: United States
Sponsor: University of California, Los Angeles
Condition: Addiction

Drug study icon

CompletedNCT02537574

Naltrexone for Use in Conjunction With Buprenorphine in Adults With Addiction Prior to First Dose of VIVITROL® (Naltrexone for Extended-Release Injectable Suspension)

This study is completed in the United States. It focuses on Addiction.

In United States

AddictionDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: Alkermes, Inc.
Condition: Addiction

Drug study icon

CompletedNCT04935931

Naltrexone Neuroimaging

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Eating disordersDrugFrom 13 Years to 21 Years

Countries: United States
Sponsor: Children's Mercy Hospital Kansas City
Condition: Eating disorders

Drug study icon

TerminatedNCT00758966

Naltrexone SR and Fluoxetine Combination Therapy in Subjects With OCD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

OCDDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: Orexigen Therapeutics, Inc
Condition: OCD

Drug study icon

CompletedNCT00000448

Naltrexone Treatment for Alcoholic Women

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Eating disordersDrugFrom 18 Years to 50 Years

Countries: United States
Sponsor: Yale University
Condition: Eating disorders

Drug study icon

CompletedNCT00145847

Naltrexone Treatment of Alcohol Abuse in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 69 Years

Countries: United States
Sponsor: State University of New York - Upstate Medical University
Condition: Schizophrenia

Drug study icon

TerminatedNCT03132571

Naltrexone-Bupropion Versus Placebo-Bupropion for Weight Loss in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 75 Years

Countries: United States
Sponsor: Yale University
Condition: Schizophrenia

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.